Digital X-ray firm Nanox scoops up AI developer Zebra Medical Imaginative and prescient

Digital x-ray imaging firm Nanox introduced plans to accumulate two firms Tuesday, Zebra Medical Imaginative and prescient and USARAD Holdings.

Nanox mentioned it entered into an settlement to accumulate AI developer Zebra Medical Imaginative and prescient in an all-stock transaction for $100 million upfront after which one other $100 million tied to efficiency. 

Nanox additionally signed a binding letter of intent to accumulate teleradiology supplier USARAD and its associated firm, Medical Diagnostics Internet, for $30 million: $21 million of Nanox shares and $9 million in money.

Along with the acquisition, Nanox introduced monetary outcomes for its second quarter ended June 30. The corporate reported a web lack of $13.6 million, in contrast with a web lack of $6.4 million for a similar quarter in 2020.

Nanox studies the loss to elevated analysis and growth, advertising prices and administrative bills as the corporate builds out its administration crew.


Nanox scored FDA clearance for its Nanox.ARC digital x-ray in April. The system combines an in-hospital scanning system, which acquired clearance, with a companion cloud software program software, which hasn’t but been authorized.

Nanox claimed its system could be inexpensive and simpler for hospitals to arrange. However the firm hit some main roadblocks in its path to approval.

The corporate had initially utilized to the FDA in 2020, and in February 2021, the company requested extra details about their submission. In response to an SEC submitting, Nanox wanted “to deal with sure deficiencies and questions, together with requests that the Firm present further assist relating to the supposed use of the Nanox.ARC and the comparability of the Nanox.ARC to the predicate system.” 

And in September of final yr, a report by Andrew Left’s Citron Analysis, a inventory evaluation and commentary weblog that goals to label overpriced or fraudulent shares, known as the corporate “Theranos 2.0.”

“Nanox believes that the allegations within the report are fully with out advantage and strongly condemns the publishing of the false and deceptive info contained on this report,” the corporate mentioned in an announcement on the time. “The corporate is fastidiously reviewing the report and can present further info on the allegations as acceptable.”

Nanox then gave a reside, digital demonstration of its imaging know-how in December on the Radiology Society of North America’s annual assembly.

Within the firm’s acquisition and second quarter outcomes announcement, Nanox reiterated its plans to deploy 15,000 Nanox.ARC techniques by the tip of 2024.


“The worldwide scarcity of skilled radiologists represents a big bottleneck within the imaging course of. The Nanox.ARC, along with the acquisitions of Zebra Medical Imaginative and prescient and USARAD, if consummated, would enable us to assist our techniques with a big community of radiologists empowered with extremely superior AI algorithms,” Ran Poliakine, chairman and CEO of Nanox, mentioned in an announcement. “This end-to-end, globally linked medical imaging resolution will enable for the speedy interpretation of medical pictures into actionable medical interventions and would additionally symbolize a big step towards our imaginative and prescient of true inhabitants preventive healthcare.”

Supply hyperlink

What's your reaction?

In Love
Not Sure

You may also like

More in:Health

Leave a reply

Your email address will not be published. Required fields are marked *